Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
zx zx zx zx zx zx zx
Author: Teri Moser Woo and Wendy L. Wright ||Complete A+ Guide
zx zx zx zx zx zx zx zx zx zx
, TABLE OF CONTENT
zx zx
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber .................................................................4
zx zx zx zx zx zx zx zx zx zx
Chapter 2. Review of Basic Principles of Pharmacology ...................................................................................5
zx zx zx zx zx zx zx
Chapter 3. Rational Drug Selection ................................................................................................................... 11
zx zx zx zx
Chapter 4. Legal and Professional Issues in Prescribing ................................................................................. 14
zx zx zx zx zx zx zx
Chapter 5. zx zx Adverse Drug Reactions .................................................................................................................. 16
zx zx
Chapter 6. zx zx An Introduction to Pharmacogenomics ........................................................................................... 19
zx zx zx
Chapter 7. zx zx Nutrition and Nutraceuticals............................................................................................................ 22
zx zx
Chapter 8. zx zx Herbal Therapies .............................................................................................................................. 28
zx
Chapter 9. Cannabis ........................................................................................................................................... 31
zx zx
Chapter 10. Pharmacoeconomics ....................................................................................................................... 35
zx zx
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................ 38
zx zx zx zx zx zx zx
Chapter 12.zx zx Drugs zx Affecting the zx zx Central Nervous System .............................................................................. 45
zx zx
Chapter 13.zx zx Drugs zx Affecting the zx zx Cardiovascular and Renal Systems............................................................. 53
zx zx zx
Chapter 14.zx zx Drugs zx Affecting the zx zx Respiratory System ...................................................................................... 61
zx
Chapter 15.zx zx Drugs zx Affecting the zx zx Hematological System ................................................................................. 65
zx
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ..................................... 69
zx zx zx zx zx zx zx zx zx
Chapter 17. Drugs Affecting the Immune System: Immunomodulators .......................................................... 75
zx zx zx zx zx zx zx
Chapter 18. Drugs Affecting the Gastrointestinal System ............................................................................... 77
zx zx zx zx zx zx
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs............... 80
zx zx zx zx zx zx zx zx zx zx zx
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ....................... 83
zx zx zx zx zx zx zx zx zx zx zx
Chapter 21. Drugs Affecting the Reproductive System ................................................................................... 86
zx zx zx zx zx zx
Chapter 22. Drugs Affecting the Bones and Joints .......................................................................................... 92
zx zx zx zx zx zx zx
Chapter 23. Drugs Affecting the Integumentary System.................................................................................. 96
zx zx zx zx zx zx
Chapter 24. Drugs Used to Treat Bacterial Infections ....................................................................................101
zx zx zx zx zx zx zx
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ...................................................105
zx zx zx zx zx zx zx zx zx zx
Chapter 26. Drugs Used to Treat Inflammatory Processes .............................................................................108
zx zx zx zx zx zx zx
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ..............................................................................111
zx zx zx zx zx zx zx zx zx
Chapter 28. Anemia ..........................................................................................................................................113
zx zx
Chapter 29.zx zx Anxiety and Depression................................................................................................................116
zx zx
Chapter 30.zx zx Attention Deficit-Hyperactivity Disorder .....................................................................................120
zx zx
Chapter 31.zx zx Asthma and Allergy......................................................................................................................122
zx zx
Chapter 32.zx zx Chronic Obstructive Pulmonary Disease......................................................................................125
zx zx zx
Chapter 33. Contraception.................................................................................................................................127
zx zx
Chapter 34. COVID-19: Acute and Chronic ...................................................................................................130
zx zx zx zx zx
Chapter 35. Dermatological Conditions............................................................................................................134
zx zx zx
Chapter 36. Diabetes Management ...................................................................................................................138
zx zx zx
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease....................................................................146
zx zx zx zx zx zx zx
Chapter 38. Headaches ......................................................................................................................................149
zx zx
Chapter 39. Heart Failure .................................................................................................................................153
zx zx zx
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome..........................................................158
zx zx zx zx zx zx zx
Chapter 41. Menopausal Hormone Therapy ....................................................................................................161
zx zx zx zx
,Chapter 42. Hyperlipidemia ..............................................................................................................................164
zx zx
Chapter 43. Hypertension..................................................................................................................................169
zx zx
Chapter 44. Hyperthyroidism and Hypothyroidism .........................................................................................174
zx zx zx zx
Chapter zx 45. zxObesity...........................................................................................................................................177
Chapter zx 46. zxPain Management: Acute and Chronic Pain ...............................................................................181
zx zx zx zx zx
Chapter zx 47. zxPneumonia .....................................................................................................................................185
Chapter zx 48. zxSexually Transmitted Diseases and Vaginitis ..............................................................................187
zx zx zx zx
Chapter 49. Substance Use Disorders ..............................................................................................................190
zx zx zx zx
Chapter 50. Tuberculosis ..................................................................................................................................195
zx zx
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......197
zx zx zx zx zx zx zx zx zx zx zx zx
Chapter 52. Urinary Tract Infections ...............................................................................................................200
zx zx zx zx
Chapter 53. Women as Patients .......................................................................................................................203
zx zx zx zx
Chapter 54. Men as Patients .............................................................................................................................207
zx zx zx zx
Chapter 55. Pediatric Patients ...........................................................................................................................209
zx zx zx
Chapter 57. Geriatric Patients ...........................................................................................................................213
zx zx zx
, Woo 1
Pharmacotherapeutics for APN Prescribers, zx zx zx Ch01
6e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
zx zx zx zx zx zx zx zx zx zx
MULTIPLE CHOICE zx
1. Nurse practitioner prescriptive authority is regulated by:
zx zx zx zx zx zx
A. The National Council of State Boards of Nursing
zx zx zx zx zx zx zx
B. The U.S. Drug Enforcement Administration
zx zx zx zx
C. The State Board of Nursing for each state
zx zx zx zx zx zx zx
D. The State Board of zx zx zx
zx Pharmacy zx
ANSWER>> C zx POINT(S): zx
zx 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN)
zx zx zx zx zx zx zx zx zx zx zx zx
prescriber include:
zx zx
A. Nurses know more about pharmacology than other prescribers because they take
zx zx zx zx zx zx zx zx zx zx
it both in their basic nursing program and in their APRN program.
zx zx zx zx zx zx zx zx zx zx zx zx
B. Nurses care for the patient from a holistic approach and include the patient
zx zx zx zx zx zx zx zx zx zx zx zx
in decision-making regarding their care.
zx zx zx zx zx
C. APRNs are less likely to prescribe narcotics and other controlled substances.
zx zx zx zx zx zx zx zx zx zx
D. APRNs are able to prescribe independently in all states, whereas a
zx zx zx zx zx zx zx zx zx zx
physician’s assistant needs to have a physician supervising their practice.
zx zx zx zx zx zx zx zx zx zx
ANSWER>> B zx POINT(S): zx z x 1
3. Clinical judgment in prescribing includes:
zx zx zx zx
A. Factoring in the cost to the patient of the medication prescribed
zx zx zx zx zx zx zx zx zx zx
B. Always prescribing the newest medication available for the disease process
zx zx zx zx zx zx zx zx zx
C. Handing out drug samples to poor patients zx zx zx zx zx zx
D. Prescribing all generic medications to cut zx zx zx zx zx
costs ANSWER>> A
zx zx zx POINT(S): zx z x 1
4. The process for choosing an effective drug for a disorder includes:
zx zx zx zx zx zx zx zx zx zx
A. Asking the patient what drug they think would work best for them
zx zx zx zx zx zx zx zx zx zx zx
B. Consulting nationally recognized guidelines for disease management
zx zx zx zx zx zx
C. Prescribing medications that are available as samples before writing a prescription
zx zx zx zx zx zx zx zx zx zx
D. Following U.S. Drug Enforcement Administration guidelines for
zx zx zx zx zx zx
prescribing ANSWER>> B
zx zx zx POINT(S): zx z x 1
5. Nonintentional nonadherence of drug therapy may occur due to: zx zx zx zx zx zx zx zx
A. Belief that medication does not work
zx zx zx zx zx
B. Adverse drug reactions zx zx
C. Chronic conditions that require daily therapy
zx zx zx zx zx
D. Forgetfulness or distraction zx zx
zx ANSWER>> D zx POINT(S): zx
zx 1